SEC Form 5 · accession 0001209191-15-025244
ReShape Lifesciences Inc. · RSLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory S Lea
Officer — SVP, CFO and COO
Period of report
Dec 31, 2012
Accepted (ET)
Mar 11, 2015 · 5:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001371217
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 13, 2012 | S | 10,500 | $2.5637 | D | 2,750 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person's shares are held in an account administered by a bank. The total number held reflects a reduction of shares held as of 12/31/2012 to reflect an inadvertent instruction by the bank, without notification to or authorization by the reporting person, to sell the shares noted.